Harnessing the Immune System against Osteosarcoma

by Katie Nightingale | Feb 2, 2023 | Research

In the last 30 years there has been very little change to osteosarcoma (OS) treatment. We are dedicated to changing this. Through the Myrovlytis Trust, we fund research into OS, with a focus on finding new treatments. We are pleased to announce we have awarded funding...

Osteosarcoma Now – Highlights of 2022

by Jazzmin Huber | Jan 13, 2023 | Research, Resources and Support

Our work in osteosarcoma (OS) started in 2021, with many months dedicated to talking with experts, patients and other charities. These initial conversations helped us to identify how best we could support patients and their families. 2022 was the year we made these...

CTOS Annual Meeting – The Highlights

by Jazzmin Huber | Dec 6, 2022 | Clinical Trials, Research

In November 2022 we attended the Connective Tissue Oncology Society (CTOS) meeting. This meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma. In this blog we highlight some of the talks with a focus on...

Metal vs Carbon-Fibre Implants in Bone Cancer Surgery

by Jazzmin Huber | Nov 29, 2022 | Research

To treat osteosarcoma (OS), surgeons will often remove the bone containing the tumour. This bone can then be replaced with a metal implant. A recent study looked at whether implants made of carbon-fibre could be an alternative to metal. Metal Implants Metal is the...

Testing Existing Drugs in Osteosarcoma Models

by Katie Nightingale | Nov 22, 2022 | Research

There is an urgent need to find new therapies in osteosarcoma (OS) that has spread or has not responded to standard treatment. Identifying new treatments can be a long and complex process. One method of speeding up the process is to use drugs that already approved to...

Using 3D Bioprinting to Study Osteosarcoma

by Katie Nightingale | Nov 15, 2022 | Research

There is a great need to develop new treatments for osteosarcoma (OS). This is particularly true for OS that has spread or has not responded to current standard therapy. Researchers are actively working towards finding new drugs to treat OS. To enable the drug...